Explore all MisterGeeks topics.
Markets and investing
Rallybio shareholders approved the planned merger with Avenzo Therapeutics, along with related corporate changes and a special distribution of $13.90 per share. The merger is expected to close on November 6, pending closing conditions.
Celebrities and pop culture
A shopping writer shares gift picks suited to city life, from personalized accessories and beauty sets to warm clothing, sneakers and a screenless camera.
Biotechnology and life sciences
The proposed acquisition would expand Lonza’s U.S. CDMO network from four sites to nine and add about 1,100 employees. The companies put the deal’s value in the low- to mid-triple-digit millions of Swiss francs.
Economy and business
A filing with Brazil’s competition authority says Cyrela is interested in acquiring some of Sabesp’s properties for future developments in São Paulo. The properties and sale price have not been disclosed.